Company: BDRX
Filing Date: 2025-01-28
Form Type: 424B3
Source: 0001214659-25-001409
Chunk: 405

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-28
Form: 424B3
Chunk 405
---
 |     |           – |     |         – |
| Total                                                |     |               |     | 6,252,900 |     |             |     | 1,108,344 |     |             |     | 1,098,469 |

At a General Meeting
on 24 March 2023, shareholders approved a consolidation of the Company’s Ordinary Shares on a one for 20 basis. As a result, the
par value of the Ordinary Shares was changed from £0.001 per share to £0.02 per share. At the same time, the ratio of the
Company’s Ordinary Shares to ADSs was changed from each ADS representing 25 Ordinary Shares to each ADS representing five Ordinary
Shares.

At a General Meeting
on 14 June 2023, shareholders approved the subdivision and redesignation of the Company’s Issued Ordinary Shares of £0.02
each into to one Ordinary Share of £0.001 each and 19 ‘B’ Deferred Shares of £0.001 each. The ‘B’
Deferred Shares have limited rights and are effectively valueless. The previously issued Deferred Shares were redesignated ‘A’
Deferred Shares.

On 5 July 2023 the Company
effected a ratio change in the number of Ordinary Shares represented by ADSs from five Ordinary Shares per ADS to 400 Ordinary Shares
per ADS.

On 26 May 2023 the Company entered into Private Placement
and on 21 December 2023 the Company entered into a Registered Offering. As no share premium was recognised in relation to these transactions
the transaction costs have been charged to retained earnings.

| F-68 |

| 21 | Share capital (continued) |

During the year the Company issued the following warrants
over ADSs, and these were recognised in the warrant reserve until exercise:

| Schedule of warrant reserve recognize    |     |   | Pre-Funded 
   Warrants |   |     |   | Series A 
 Warrants |   |     |   | Series B 
 Warrants |   |     |   | Series C 
 Warrants |   |
|:-----------------------------------------|:----|:--|-----------:|:--|:----|:--|---------:|:--|:----|:--|---------:|:--|:----|:--|---------:|:--|
| Exercise price                           |     | £ |     0.0001 |   |     | $ |   214.40